Plateau Iris Configuration

Plateau iris configuration is an anatomical variant of the anterior segment in which the peripheral iris inserts anteriorly onto the face of the ciliary body and is held forward by anteriorly positioned ciliary processes. This contrasts with primary angle closure from pupillary block — where aqueous trapped behind the iris bows the entire iris forward (iris bombé) — by maintaining a flat, non-convex central iris plane while the peripheral iris hugs the angle structures.

The clinical significance lies in the potential for angle closure. During pupil dilation — whether physiological (dim light conditions), pharmacological (mydriatics), or situational (emotional stress, dark adaptation) — the peripheral iris folds (bunches) into the angle, obstructing the trabecular meshwork and causing IOP elevation. Unlike pupillary block-mediated angle closure, laser peripheral iridotomy (LPI) alone does not address the mechanical crowding of the peripheral iris by the anteriorly placed ciliary body.

The critical diagnostic distinction is between plateau iris configuration (occludable angle on gonioscopy or UBM, no history of angle closure attack, LPI not yet performed or recently performed) and plateau iris syndrome (angle closure demonstrably persists despite a confirmed patent LPI, requiring additional intervention such as argon laser peripheral iridoplasty or lens extraction).

Ultrasound biomicroscopy (UBM) is the gold standard imaging modality for confirming the diagnosis — it directly visualises the anteriorly rotated ciliary body and ciliary processes that characterise plateau iris and distinguish it from pupillary block mechanism.

The fundamental anatomical abnormality in plateau iris is the anterior positioning and/or anterior rotation of the ciliary body. This may be an idiopathic variation in anterior segment anatomy — effectively representing the extreme of normal anatomical variation — or it may be associated with specific predisposing features.

• Idiopathic anterior ciliary body position: The ciliary body is anatomically placed more anteriorly than normal, directly holding the peripheral iris root against the trabecular meshwork. This is a primary structural variant without any identifiable genetic or metabolic cause in most cases.
• Ciliary body cysts: Multiple peripheral anterior ciliary body cysts — identifiable on UBM — physically push the ciliary processes forward, elevating the peripheral iris root into the angle. This is an important and treatable secondary cause of plateau iris configuration.
• Small eye (hyperopia): Hyperopic eyes with smaller axial lengths and shallower anterior chambers have proportionally less space for ciliary body accommodation, predisposing to more anterior ciliary body positioning.
• Thick crystalline lens: A large, thick phakic lens further reduces anterior chamber space and may contribute to peripheral angle narrowing; lens extraction is a definitive treatment option.
• Female sex and relative youth: The choroidal and ciliary body volume may be influenced by hormonal and anatomical factors; plateau iris is notably more common in younger females than typical primary angle closure disease.

In a normal anterior segment, the iris inserts at the ciliary body face at a posterior enough position to allow the peripheral iris to fall away from the angle during dilation — the iris thins and the peripheral roll moves posteriorly, opening the angle. In plateau iris, the anteriorly placed ciliary body holds the peripheral iris root in an anterior position. During dilation, instead of thinning and falling away from the angle, the peripheral iris bunches up (folds) against the trabecular meshwork.

This peripheral iris crowding produces appositional angle closure — physical contact between the peripheral iris and the trabecular meshwork that obstructs aqueous outflow and raises IOP. The central anterior chamber depth is characteristically normal or even deep (unlike pupillary block where the entire iris bows forward and the central AC is shallow). On gonioscopy, this produces the pathognomonic "double hump" sign: the central iris plane is flat or slightly convex, but a secondary bump is visible at the peripheral iris root where it is held up by the underlying anteriorly placed ciliary process before the peripheral iris drops into the angle.

Because the underlying mechanism is the physical anterior position of the ciliary body rather than aqueous pressure trapped behind the iris (pupillary block), laser peripheral iridotomy — which eliminates pressure gradients across the iris by creating a direct aqueous pathway through the peripheral iris — does not flatten the peripheral iris. The LPI eliminates any coexisting pupillary block component but does not change the ciliary body position; hence the angle can remain occludable (plateau iris syndrome) despite a functioning LPI.

Sustained appositional closure leads to peripheral anterior synechiae (PAS) formation as the iris adheres to the trabecular meshwork over time, progressively reducing aqueous outflow capacity and establishing chronic angle-closure glaucoma.

• Female sex: Plateau iris has a significantly higher prevalence in females than typical primary angle closure disease, and tends to present at a younger age (40s–50s vs 60s for typical angle closure).
• Middle age (~40–60 years): The condition becomes clinically apparent in mid-life, in contrast to pupillary block angle closure which typically presents in the 6th–7th decade.
• Hyperopia: Hyperopic eyes (short axial length, smaller anterior segment dimensions) predispose to narrower angles and anterior ciliary body positioning.
• Asian ethnicity: East and South-East Asian populations have shallower anterior chambers and more anteriorly positioned ciliary bodies on average, contributing to higher rates of all angle-closure subtypes including plateau iris.
• Family history of angle closure: A positive family history should prompt gonioscopic screening and UBM assessment.
• Ciliary body cysts: A potentially modifiable secondary risk factor; identifiable on UBM.
• Thick crystalline lens: Phakic lens thickness reduces anterior chamber volume; lens extraction is a definitive intervention.
• Medications causing pupil dilation: Antihistamines, antidepressants (tricyclics, SSRIs with weak anticholinergic properties), decongestants, anti-Parkinson medications — all can precipitate angle closure in plateau iris.

Slit-lamp examination: The central anterior chamber depth is typically normal — this is a critical distinguishing feature from pupillary block angle closure where the central AC is markedly shallow with a convex, bowed-forward iris plane. The peripheral iris has a characteristic flat or slightly raised appearance, and the iris plane is flat rather than convex when viewed in cross-section. There is no iris bombé (the pupillary block sign of forward bowing of the entire iris).

Gonioscopy (essential — most important clinical sign): The "double hump" sign — when the gonioscopy lens illuminates the peripheral angle, the iris profile shows a central flat plateau with a peripheral bump at the last iris roll before the trabecular meshwork, caused by the anteriorly placed ciliary processes lifting the peripheral iris root. The angle may be narrow or closed at the periphery despite normal central AC depth. Peripheral anterior synechiae (PAS) may be present in advanced or longstanding cases. After LPI: the angle remains narrow or occludable in plateau iris syndrome, confirming that the LPI has not opened the angle.

UBM (gold standard for diagnosis): Directly visualises the anteriorly rotated ciliary body and anteriorly positioned ciliary processes immediately behind the peripheral iris — the ciliary processes appear to physically prop up the iris root. The iris insertion on the ciliary body face is anterior. Ciliary body cysts are identifiable on UBM.

Iris appearance: Normal colour and texture; no iris atrophy or abnormality. The pupil is typically normal size and reactive. No iris nodules, KPs, or other inflammatory signs.

Fundus: Optic disc assessment for glaucomatous damage; cup-disc ratio, RNFL. Visual field testing for scotomas in established chronic angle closure glaucoma cases.

• Asymptomatic (plateau iris configuration): Many patients are completely asymptomatic and are identified incidentally on gonioscopic screening during routine examination for narrow angles or following a fellow eye angle closure event.
• Intermittent haloes and blur: Episodes of mildly elevated IOP from subacute intermittent angle closure in dim light or during emotional arousal produce transient haloes around lights and blurring, often resolving spontaneously as the pupil re-constricts in light.
• Acute angle closure attack: Severe throbbing eye pain (often periorbital), nausea and vomiting, markedly decreased vision, redness, and visible corneal oedema (cornea appears dull/hazy). Typically precipitated by dim light, emotional upset, or a mydriatic agent. An acute attack with plateau iris syndrome is clinically indistinguishable from pupillary block acute angle closure at presentation.
• Chronic progressive visual field loss: In longstanding plateau iris syndrome with chronic angle closure and glaucoma — gradual, insidious peripheral then central visual field constriction, often not noticed until advanced.

• Acute angle closure glaucoma: Precipitated by dilation (dim light, mydriatics, stress); presents with severe pain, nausea, markedly elevated IOP (>40–60 mmHg), corneal oedema, and dramatically reduced VA. A true ocular emergency.
• Chronic angle closure glaucoma: Progressive, often silent angle closure producing PAS formation and cumulative trabecular damage; leads to irreversible optic nerve injury and visual field loss.
• Peripheral anterior synechiae (PAS): Progressive angle adhesions reduce aqueous outflow reserve; once formed, PAS cannot be reversed (though laser treatment can prevent further formation).
• Corneal oedema: During acute angle closure attack from severe IOP elevation and endothelial stress; typically reversible with IOP normalisation.
• Optic atrophy: From sustained elevated IOP during acute attacks or chronic glaucoma; permanent visual field loss.
• Cataract: May develop acutely from IOP spike during angle closure attack (glaukomflecken — grey-white anterior subcapsular lens opacities); also from chronic treatment with pilocarpine (myotic cataract).

Plateau iris configuration does not have specific systemic disease associations in the majority of cases — it represents a primary anatomical variant. However, the following factors are relevant:

• Ciliary body cysts (multiple): Peripheral ciliary body cysts are the most clinically significant secondary cause; they may be idiopathic or associated with systemic conditions. When numerous, they can dramatically push the ciliary body anteriorly.
• Hyperopia: Significant hyperopia requiring thick plus spectacle lenses is associated with small eye dimensions; the patient's cardiometabolic and other systemic profile does not directly contribute to plateau iris.
• Medications that precipitate angle closure: Clinicians should be alert to systemic drug classes that cause pupil dilation — tricyclic antidepressants, antihistamines (chlorpheniramine, promethazine), antispasmodics, antiparkinsonian drugs, and nebulised bronchodilators (ipratropium). In a patient with known plateau iris syndrome, prescribing clinicians should be informed.
• Female hormonal factors: The preponderance of plateau iris in younger women has prompted speculation about a role of oestrogen in determining choroidal/ciliary body volume, though direct evidence is limited.

Gonioscopy (most important clinical tool): Mandatory in all cases of narrow angle or suspected angle closure. The "double hump" sign — characteristic flat central iris with a peripheral bump from underlying ciliary processes — is pathognomonic. Assess angle grade (Shaffer, Spaeth), PAS extent, and document whether the LPI is patent. Re-evaluate angle after LPI to confirm whether closure persists (defining plateau iris syndrome).

Ultrasound biomicroscopy (UBM) — gold standard: Directly images the anterior segment at high resolution, revealing the anteriorly rotated ciliary body, anteriorly positioned ciliary processes physically supporting the peripheral iris root, and any ciliary body cysts. Flat central iris with steep peripheral drop confirmed. This examination provides definitive anatomical confirmation of plateau iris mechanism.

AS-OCT (anterior segment OCT): Non-contact, rapid assessment of angle width (ACA, AOD500, TISA parameters); identifies narrow angles and can detect changes after LPI and ALPI. Does not provide ciliary body imaging (unlike UBM) but is excellent for serial angle monitoring and patient compliance.

Provocative testing: Prone dark room test — patient lies prone in the dark for 30–60 minutes; IOP rise >8 mmHg or angle closure on gonioscopy constitutes a positive result. Pharmacological dilation test with IOP monitoring (tropicamide 0.5% — shorter-acting agent) may be considered under ophthalmological supervision with reversal agent (pilocarpine) available. These tests are performed in patients with confirmed plateau iris to assess the risk of clinically significant angle closure.

Corneal topography and keratometry: AS-OCT central AC depth; Pentacam for anterior chamber volume and angle parameters.

Visual field testing and optic disc assessment: Establish baseline visual field (Humphrey 24-2 or 30-2 SITA); OCT RNFL and optic disc imaging for glaucoma surveillance; repeat annually or as clinically indicated.

Plateau iris configuration carries an excellent prognosis when identified before an angle closure attack occurs and treated prophylactically with LPI. The majority of patients with pure plateau iris configuration will not have angle closure after LPI, particularly if they are counselled to avoid mydriatic medications and dim-light exposure.

Plateau iris syndrome — where angle closure persists after patent LPI — has a good prognosis with ALPI or clear lens extraction. ALPI effectively opens the angle in most cases and can be repeated if the effect wanes over years. Clear lens extraction provides more durable angle deepening and is increasingly favoured as the primary definitive intervention, particularly in hyperopic patients.

Eyes that have developed progressive synechial angle closure or glaucomatous optic nerve damage before diagnosis have a more guarded prognosis — the optic nerve damage from previous IOP elevation is irreversible. With ongoing IOP control (topical hypotensives, surgical intervention when required) and regular visual field monitoring, further progression can usually be halted.

The overall visual prognosis with appropriate management is excellent for patients who have not yet developed optic nerve damage. Regular lifelong gonioscopic and IOP monitoring remains essential, as angle changes and PAS formation can progress despite treatment.

1. Ritch R, Liebmann JM. Role of ultrasound biomicroscopy in the differentiation of block glaucomas. Current Opinion in Ophthalmology. 1998;9(2):39–45.
2. Liebmann JM, Ritch R. Ultrasound biomicroscopy of the anterior segment. Journal of American Academy of Ophthalmology. 1996;103(7):1132–1145.
3. Robin AL, Pollack IP. Argon laser peripheral iridotomies in the treatment of primary angle closure glaucoma. Archives of Ophthalmology. 1982;100(6):919–923.
4. Tran HV, Liebmann JM, Ritch R. Iridociliary apposition in plateau iris syndrome persists after cataract extraction. American Journal of Ophthalmology. 2003;135(1):40–43.
5. Ritch R, Tham CC, Lam DS. Long-term success of argon laser peripheral iridoplasty in the management of plateau iris syndrome. Ophthalmology. 2004;111(1):104–108.
6. Friedman DS, He M. Anterior chamber angle assessment techniques. Survey of Ophthalmology. 2008;53(3):250–273.
7. Quigley HA, Friedman DS, Congdon NG. Possible mechanisms of primary angle-closure and malignant glaucoma. Journal of Glaucoma. 2003;12(2):167–180.